Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks
UHPLC-MS/MS assay for simultaneous determination of amlodipine, metoprolol, pravastatin, rosuvastatin, atorvastatin with its active metabolites in human plasma, for population-scale drug-drug interactions studies in people living with HIV
Marzolini, C.; Telenti, A.; Buclin, T.; Biollaz, J.; Decosterd, L. A.
2000
Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction
Fellay, Jacques; Marzolini, Catia; Meaden, Emma R.; Back, David J.; Buclin, Thierry; Chave, Jean Philippe; Decosterd, Laurent A.; Furrer, Hansjakob; Opravil, Milos; Pantaleo, Giuseppe; Retelska, Dorota; Ruiz, Lidia; Schinkel, Alfred H.; Vernazza, Pietro; Eap, Chin B.; Telenti, Amalio; Swiss HIV Cohort Study,
2002
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study
Repository describing an aging population to inform physiologically based pharmacokinetic models considering anatomical, physiological, and biological age-dependent changes
Schlaeppi, C.; Vanobberghen, F.; Sikalengo, G.; Glass, T. R.; Ndege, R. C.; Foe, G.; Kuemmerle, A.; Paris, D. H.; Battegay, M.; Marzolini, C.; Weisser, M.; Kilombero Ulanga Antiretroviral Cohort study group,
2019
Prevalence and management of drug-drug interactions with antiretroviral treatment in 2069 people living with HIV in rural Tanzania: a prospective cohort study
Prediction of drug-drug interactions between various antidepressants and efavirenz or boosted protease inhibitors using a physiologically based pharmacokinetic modelling approach